Functional outcomes related to the prevention of radiation-induced xerostomia: Oral pilocarpine versus submandibular salivary gland transfer

Head and Neck

Volumn 34, Issue 2, 2012, Pages 168-174

  Rieger, Jana M ^a,b   Jha, Naresh ^a,b   Lam Tang, Judith A ^a,b   Harris, Jeffrey ^a,b,c   Seikaly, Hadi ^a,b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Misericordia Community Hospital   (Canada)

^c UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

oral pilocarpine; quality of life; speech; submandibular gland transfer; swallowing

Indexed keywords

PILOCARPINE;

ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORAL SURGERY; PRIORITY JOURNAL; QUALITY OF LIFE; SPEECH INTELLIGIBILITY; SUBMANDIBULAR SALIVARY GLAND TRANSFER; SWALLOWING; TREATMENT OUTCOME; XEROSTOMIA;

ADMINISTRATION, ORAL; HEAD AND NECK NEOPLASMS; HUMANS; MULTIVARIATE ANALYSIS; MUSCARINIC AGONISTS; PILOCARPINE; QUALITY OF LIFE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SALIVARY GLANDS; SUBMANDIBULAR GLAND; TREATMENT OUTCOME; XEROSTOMIA;

EID: 80053013520     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21682     Document Type: Article

References (42)

1. Momm F, Lutterbach J,. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia: in regard to Ringash et al. (Int J Radiat Oncol Biol Phys 2005; 61: 1403-1407). Int J Radiat Oncol Biol Phys 2005; 63: 969; author reply 969-970.
2. Guchelaar HJ, Vermes A, Meerwaldt JH,. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer 1997; 5: 281-288. (Pubitemid 27305078)
3. Vissink A, Panders AK, Gravenmade EJ, Vermey A,. The causes and consequences of hyposalivation. Ear Nose Throat J 1988; 67: 166-176.
4. Hughes CV, Baum BJ, Fox PC, Marmary Y, Yen CK, Sonies BC,. Oral-pharyngeal dysphagia: a common sequela of salivary gland dysfunction. Dysphagia 1987; 1: 173-177. (Pubitemid 18030896)
5. Ohrn KE, Wahlin YB, Sjödén PO,. Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications. Support Care Cancer 2001; 9: 247-257. (Pubitemid 32537283)
6. Hamburger J,. Sjörgen's syndrome as seen by an oral physician. Scand J Rheumatol Suppl 2001; 115: 34-38; discussion 38-39.
7. Young W, Khan F, Brandt R, Savage N, Razek AA, Huang Q,. Syndromes with salivary dysfunction predispose to tooth wear: case reports of congenital dysfunction of major salivary glands, Prader-Willi, congenital rubella, and Sjörgen's syndromes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 38-48. (Pubitemid 33601700)
8. Specht L,. Oral complications in the head and neck radiation patient. Introduction and scope of the problem. Support Cancer Care 2002; 10: 36-39. (Pubitemid 36055882)
9. Davis MP, Dickerson D,. Cachexia and anorexia: cancer's covert killer. Support Care Cancer 2000; 8: 180-187. (Pubitemid 30183033)
10. Logemann JA, Smith CH, Pauloski BR, et al. Effects of xerostomia on perception and performance of swallow function. Head Neck 2001; 23: 317-321. (Pubitemid 32234110)
11. Ruben RJ,. Redefining survival of the fittest: communication disorders in the 21st century. Laryngoscope 2000; 110 (2 Pt 1): 241-245. (Pubitemid 30090855)
12. De Boer MF, McCormick LK, Pruyn JF, Ryckman RM, van den Borne BW,. Physical and psychosocial correlates of head and neck cancer: a review of the literature. Otolaryngol Head Neck Surg 1999; 120: 427-436. (Pubitemid 29135882)
13. Allal AS, Dulguerov P, Bieri S, Lehmann W, Kurtz JM,. Assessment of quality of life in patients treated with accelerated radiotherapy for laryngeal and hypopharyngeal carcinomas. Head Neck 2000; 22: 288-293. (Pubitemid 30215326)
14. List MA, Stracks J,. Evaluation of quality of life in patients definitively treated for squamous carcinoma of the head and neck. Curr Opin Oncol 2000; 12: 215-220. (Pubitemid 32042734)
15. Seikaly H, Jha N, McGaw T, Coulter L, Liu R, Oldring D,. Submandibular gland transfer: a new method of preventing radiation-induced xerostomia. Laryngoscope 2001; 111: 347-352. (Pubitemid 32143759)
16. Jha N, Seikaly H, McGaw T, Coulter L,. Submandibular salivary gland transfer prevents radiation induced xerostomia. Int J Radiat Oncol Biol Phys 2000; 46: 7-11. (Pubitemid 30021472)
17. Jha N, Seikaly H, Harris J, et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol 2003; 66: 283-289. (Pubitemid 36556047)
18. Seikaly H, Jha N, Harris JR, et al. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Arch Otolaryngol Head Neck Surg 2004; 130: 956-961. (Pubitemid 39045603)
19. Al-Qahtani K, Hier MP, Sultanum K, Black MJ,. The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 753-756. (Pubitemid 43775463)
20. Pathak KA, Bhalavat RL, Mistry RC, et al. Upfront submandibular salivary gland transfer in pharyngeal cancers. Oral Oncology 2004; 40: 960-963. (Pubitemid 39369570)
21. Jha N, Seikaly H, Harris J, et al. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia. Head Neck 2009; 31: 234-243.
22. Rieger J, Seikaly H, Jha N, et al. Submandibular gland transfer for prevention of xerostomia after radiation therapy: swallowing outcomes. Arch Otolaryngol Head Neck Surg 2005; 131: 140-145. (Pubitemid 40204771)
23. Haddad P, Karimi M,. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia. Radiother Oncol 2002; 64: 29-32. (Pubitemid 35223150)
24. Zimmerman RP, Mark RJ, Tran LM, Juillard GF,. Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys 1997; 37: 571-575. (Pubitemid 27175312)
25. Valdez IH, Wolff A, Atkinson JC, Macynski AA, Fox PC,. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer 1993; 71: 1848-1851. (Pubitemid 23067404)
26. Warde P, O'Sullivan B, Aslanidis J, et al. A phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002; 54: 9-13.
27. Fox PC, Busch KA, Baum BJ,. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 1987; 115: 581-584.
28. Wijers OB, Levendag PC, Braaksma MM, Boonzaaijer M, Visch LL, Schmitz PI,. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck 2002; 24: 737-747. (Pubitemid 34857299)
29. Henson BS, Inglehart MR, Eisbruch A, Ship JA,. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncology 2001; 37: 84-93.
30. Ringash J, Warde P, Lockwood G, O'Sullivan B, Waldron J, Cummings B,. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys 2005; 61: 1403-1407. (Pubitemid 40470421)
31. Pauloski BR, Rademaker AW, Logemann JA, et al. Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 2002; 24: 555-565. (Pubitemid 34568557)
32. Hughes PJ, Scott PM, Kew J, et al. Dysphagia in treated nasopharyngeal cancer. Head Neck 2000; 22: 393-397. (Pubitemid 30413306)
33. Smith CH, Logemann JA, Colangelo LA, Rademaker AW, Pauloski BR,. Incidence and patient characteristics associated with silent aspiration in the acute care setting. Dysphagia 1999; 14: 1-7. (Pubitemid 29043842)
34. Yorkston K, Beukelman D,. Assessment of Intelligibility of Dysarthric Speech. Portland Oregon: CC Publications: 1981
35. Harari PM,. Promising new advances in head and neck radiotherapy. Ann Oncol 2005; 16 Suppl 6: vi13-vi19. (Pubitemid 41487946)
36. Stachler RJ, Hamlet SL, Mathog RH, et al. Swallowing of bolus types by postsurgical head and neck cancer patients. Head Neck 1994; 16: 413-419. (Pubitemid 24262588)
37. Lazarus CL, Logemann JA, Pauloski BR, et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 1996; 106 (9 Pt 1): 1157-1166. (Pubitemid 26304609)
38. Lof GL, Robbins J,. Test-retest variability in normal swallowing. Dysphagia 1990; 4: 236-242. (Pubitemid 20149717)
39. EORTC Protocol 15941. Cited in, Fayers P, Aaronson N, Bjordal K, Curran D, Groenvold M,. EORTC QLQ Scoring Manual. Brussels: Quality of Life Study Group of the European Organisation for Research and Treatment of Cancer; 1999.
40. Hughes CV, Baum BJ, Fox PC, Marmary Y, Yeh CK, Sonies BC,. Oral-pharyngeal dysphagia: a common sequela of salivary gland dysfunction. Dysphagia 1987; 1: 173-177. (Pubitemid 18030896)
41. Fox PC, van der Ven PF, Sonies BC, Weiffenbach JM, Baum BJ,. Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc 1985; 110: 519-525.
42. Rieger JM, Zalmanowitz JG, Wolfaardt JF,. Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature. Int J Oral Maxillofac Surg 2006; 35: 581-587. (Pubitemid 43863138)